ABBVIE INC (1ABBV.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1ABBV - US00287Y1091 - Common Stock
188 EUR
-1.6 (-0.84%)
Taking everything into account, 1ABBV scores 5 out of 10 in our fundamental rating. 1ABBV was compared to 86 industry peers in the Biotechnology industry. There are concerns on the financial health of 1ABBV while its profitability can be described as average. 1ABBV has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- 1ABBV had positive earnings in the past year.
- 1ABBV had a positive operating cash flow in the past year.
- Each year in the past 5 years 1ABBV has been profitable.
- In the past 5 years 1ABBV always reported a positive cash flow from operatings.
1.2 Ratios
- With a decent Return On Assets value of 1.75%, 1ABBV is doing good in the industry, outperforming 74.42% of the companies in the same industry.
- The Return On Invested Capital of 1ABBV (15.64%) is better than 93.02% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for 1ABBV is above the industry average of 11.58%.
- The last Return On Invested Capital (15.64%) for 1ABBV is above the 3 year average (13.67%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | N/A | ||
| ROIC | 15.64% |
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
1.3 Margins
- 1ABBV has a better Profit Margin (3.94%) than 76.74% of its industry peers.
- In the last couple of years the Profit Margin of 1ABBV has declined.
- With an excellent Operating Margin value of 33.05%, 1ABBV belongs to the best of the industry, outperforming 88.37% of the companies in the same industry.
- In the last couple of years the Operating Margin of 1ABBV has declined.
- 1ABBV has a Gross Margin of 71.16%. This is in the better half of the industry: 1ABBV outperforms 61.63% of its industry peers.
- 1ABBV's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.05% | ||
| PM (TTM) | 3.94% | ||
| GM | 71.16% |
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1ABBV is creating value.
- 1ABBV has about the same amout of shares outstanding than it did 1 year ago.
- 1ABBV has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for 1ABBV is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 2.38 indicates that 1ABBV is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a decent Altman-Z score value of 2.38, 1ABBV is doing good in the industry, outperforming 70.93% of the companies in the same industry.
- 1ABBV has a debt to FCF ratio of 3.49. This is a good value and a sign of high solvency as 1ABBV would need 3.49 years to pay back of all of its debts.
- 1ABBV's Debt to FCF ratio of 3.49 is amongst the best of the industry. 1ABBV outperforms 81.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.49 | ||
| Altman-Z | 2.38 |
ROIC/WACC1.85
WACC8.43%
2.3 Liquidity
- 1ABBV has a Current Ratio of 0.72. This is a bad value and indicates that 1ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
- 1ABBV's Current ratio of 0.72 is on the low side compared to the rest of the industry. 1ABBV is outperformed by 77.91% of its industry peers.
- 1ABBV has a Quick Ratio of 0.72. This is a bad value and indicates that 1ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of 1ABBV (0.60) is worse than 77.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
- The earnings per share for 1ABBV have decreased strongly by -12.09% in the last year.
- The Earnings Per Share has been growing slightly by 2.51% on average over the past years.
- Looking at the last year, 1ABBV shows a small growth in Revenue. The Revenue has grown by 7.40% in the last year.
- Measured over the past years, 1ABBV shows a quite strong growth in Revenue. The Revenue has been growing by 11.11% on average per year.
EPS 1Y (TTM)-12.09%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%-38%
Revenue 1Y (TTM)7.4%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%9.1%
3.2 Future
- Based on estimates for the next years, 1ABBV will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.67% on average per year.
- Based on estimates for the next years, 1ABBV will show a small growth in Revenue. The Revenue will grow by 7.50% on average per year.
EPS Next Y7.3%
EPS Next 2Y19.85%
EPS Next 3Y16.87%
EPS Next 5Y13.67%
Revenue Next Year8.74%
Revenue Next 2Y9.15%
Revenue Next 3Y8.74%
Revenue Next 5Y7.5%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 23.15, which indicates a rather expensive current valuation of 1ABBV.
- Based on the Price/Earnings ratio, 1ABBV is valued cheaply inside the industry as 81.40% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Earnings ratio of 26.94, 1ABBV is valued at the same level.
- 1ABBV is valuated correctly with a Price/Forward Earnings ratio of 15.04.
- 1ABBV's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1ABBV is cheaper than 88.37% of the companies in the same industry.
- 1ABBV is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.94, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.15 | ||
| Fwd PE | 15.04 |
4.2 Price Multiples
- 1ABBV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. 1ABBV is cheaper than 77.91% of the companies in the same industry.
- 83.72% of the companies in the same industry are more expensive than 1ABBV, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.63 | ||
| EV/EBITDA | 15.94 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The decent profitability rating of 1ABBV may justify a higher PE ratio.
- 1ABBV's earnings are expected to grow with 16.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.17
PEG (5Y)9.22
EPS Next 2Y19.85%
EPS Next 3Y16.87%
5. Dividend
5.1 Amount
- 1ABBV has a Yearly Dividend Yield of 3.19%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 0.75, 1ABBV pays a better dividend. On top of this 1ABBV pays more dividend than 97.67% of the companies listed in the same industry.
- 1ABBV's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.19% |
5.2 History
- The dividend of 1ABBV is nicely growing with an annual growth rate of 7.72%!
Dividend Growth(5Y)7.72%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 489.69% of the earnings are spent on dividend by 1ABBV. This is not a sustainable payout ratio.
- 1ABBV's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP489.69%
EPS Next 2Y19.85%
EPS Next 3Y16.87%
BIT:1ABBV (1/13/2026, 7:00:00 PM)
188
-1.6 (-0.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-31 2025-10-31/bmo
Earnings (Next)02-04 2026-02-04/amc
Inst Owners75.04%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap332.27B
Revenue(TTM)59.64B
Net Income(TTM)2.35B
Analysts78.38
Price Target214.9 (14.31%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.19% |
Yearly Dividend5.38
Dividend Growth(5Y)7.72%
DP489.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.85%
Min EPS beat(2)0.95%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.21%
Min EPS beat(4)0.02%
Max EPS beat(4)2.75%
EPS beat(8)7
Avg EPS beat(8)0.95%
EPS beat(12)9
Avg EPS beat(12)0.65%
EPS beat(16)11
Avg EPS beat(16)0.49%
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)0.63%
Revenue beat(4)2
Avg Revenue beat(4)0.22%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.31%
Revenue beat(12)5
Avg Revenue beat(12)-0.17%
Revenue beat(16)5
Avg Revenue beat(16)-0.74%
PT rev (1m)0.67%
PT rev (3m)8.63%
EPS NQ rev (1m)-3.35%
EPS NQ rev (3m)-2.56%
EPS NY rev (1m)0.02%
EPS NY rev (3m)-11.46%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)0.48%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.15 | ||
| Fwd PE | 15.04 | ||
| P/S | 6.48 | ||
| P/FCF | 19.63 | ||
| P/OCF | 18.53 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.94 |
EPS(TTM)8.12
EY4.32%
EPS(NY)12.5
Fwd EY6.65%
FCF(TTM)9.58
FCFY5.09%
OCF(TTM)10.15
OCFY5.4%
SpS29.01
BVpS-1.29
TBVpS-45.04
PEG (NY)3.17
PEG (5Y)9.22
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | N/A | ||
| ROCE | 20.86% | ||
| ROIC | 15.64% | ||
| ROICexc | 16.59% | ||
| ROICexgc | 572.43% | ||
| OM | 33.05% | ||
| PM (TTM) | 3.94% | ||
| GM | 71.16% | ||
| FCFM | 33% |
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
ROICexc(3y)15.06%
ROICexc(5y)13.91%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.54%
ROCE(5y)16.27%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.81%
ROICexc growth 5Y-14.87%
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
F-Score7
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.49 | ||
| Debt/EBITDA | 2.39 | ||
| Cap/Depr | 14.25% | ||
| Cap/Sales | 1.97% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.59% | ||
| Profit Quality | 838.33% | ||
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 2.38 |
F-Score7
WACC8.43%
ROIC/WACC1.85
Cap/Depr(3y)9.59%
Cap/Depr(5y)10.06%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.5%
Profit Quality(3y)361.43%
Profit Quality(5y)328.91%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.09%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%-38%
EPS Next Y7.3%
EPS Next 2Y19.85%
EPS Next 3Y16.87%
EPS Next 5Y13.67%
Revenue 1Y (TTM)7.4%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%9.1%
Revenue Next Year8.74%
Revenue Next 2Y9.15%
Revenue Next 3Y8.74%
Revenue Next 5Y7.5%
EBIT growth 1Y27.38%
EBIT growth 3Y-5.38%
EBIT growth 5Y3.87%
EBIT Next Year9.3%
EBIT Next 3Y15.61%
EBIT Next 5Y10.95%
FCF growth 1Y-20.4%
FCF growth 3Y-6.75%
FCF growth 5Y6.9%
OCF growth 1Y-18.24%
OCF growth 3Y-6.19%
OCF growth 5Y7.14%
ABBVIE INC / 1ABBV.MI FAQ
Can you provide the ChartMill fundamental rating for ABBVIE INC?
ChartMill assigns a fundamental rating of 5 / 10 to 1ABBV.MI.
What is the valuation status of ABBVIE INC (1ABBV.MI) stock?
ChartMill assigns a valuation rating of 6 / 10 to ABBVIE INC (1ABBV.MI). This can be considered as Fairly Valued.
What is the profitability of 1ABBV stock?
ABBVIE INC (1ABBV.MI) has a profitability rating of 6 / 10.
What is the valuation of ABBVIE INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ABBVIE INC (1ABBV.MI) is 23.15 and the Price/Book (PB) ratio is -146.28.
Can you provide the dividend sustainability for 1ABBV stock?
The dividend rating of ABBVIE INC (1ABBV.MI) is 6 / 10 and the dividend payout ratio is 489.69%.